Delivery Order SPE2DB24D2003-SPE2DB25FXLB8

AmerisourceBergen Drug Corp received a $7,647.94 delivery order from the Defense Logistics Agency (DLA) on July 25, 2025, for the supply of RINVOQ ER 30 mg tablets (30-count units). This firm fixed-price contract, which is not a set-aside award, represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract specifies a place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters, with an ultimate completion date of July 28, 2025.

This delivery order falls within AmerisourceBergen's comprehensive $999.999 billion IDC with the DLA Troop Support Medical, designated as SPE2DX and running through December 2026. This prime contract vehicle enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including medications for various therapeutic domains. AmerisourceBergen's federal contract awards demonstrate its role as a critical vendor for military and veteran healthcare systems, with consistent competitively awarded contracts featuring firm fixed pricing across multiple product categories and order values.